Ritonavir: An extraordinary example of conformational polymorphism

Pharmaceutical Research

Volumn 18, Issue 6, 2001, Pages 859-866

  Bauer, J ^a   Spanton, S ^a   Henry, R ^a   Quick, J ^a   Dziki, W ^a   Porter, W ^a   Morris, J ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

AIDS drug; Carbamate; Crystal forms; Norvir; Polymorphism; Ritonavir

Indexed keywords

RITONAVIR;

ARTICLE; CONFORMATIONAL TRANSITION; DRUG CAPSULE; DRUG STABILITY; DRUG STRUCTURE; HYDROGEN BOND; MICROSCOPY; PRIORITY JOURNAL; SPECTROSCOPY; STRUCTURE ANALYSIS;

CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; HIV PROTEASE INHIBITORS; HYDROGEN BONDING; MOLECULAR CONFORMATION; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; RITONAVIR; SOLUBILITY; SPECTROSCOPY, NEAR-INFRARED;

EID: 0034874245     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011052932607     Document Type: Article

References (20)

1. Pharmaceutical applications of polymorphism
2. Disappearing polymorphs
3. Characterization of famotidine polymorphs
4. Polymorphism in anhydrous theophylline - Implications on the dissolution rate of theophylline tablets
5. Polymorphism and crystallization behavior of Abbott-79175, a second generation 5-lipoxygenase inhibitor
6. Sulfathiazole polymorphism studied by magic-angle spinning NMR
7. Demonstration of the terms enantiotropy and monotropy in polymorphism research exemplified by flurbiprofen
8. Solubility behavior of lamivudine crystal forms in recrystallization solvents
9. Crystal forms of piroxicam pivalate: Preparation and characterization of two polymorphs
10. A novel picomolar inhibitor of HIV type 1 protease
11. ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability
12. Potent inhibitors of HIV-1 protease with good oral bioavailabilities
13. Polymorphism and drug availability
14. Proceedings of the Fourth International Conference on Harmonization
15. Physical characterization of pharmaceutical solids
16. Uber die vermeintliche isomeric des roten und gelben quecksilberoxyds und die oberflashen spannung fester korper
17. On the polymorphism of pharmaceuticals and other molecular crystals I
18. On the polymorphism of pharmaceuticals and other molecular crystals II